Tuberculosis knowledge among New York City injection drug users

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Behavioral Science

Background:

• Tuberculosis (TB) remains a significant public health concern, especially among vulnerable populations like injection drug users (IDUs).
• Understanding TB transmission and treatment is critical for effective disease control and prevention efforts.
• Knowledge gaps among IDUs can hinder public health interventions and contribute to disease spread.

Purpose of the Study:

• To assess the level of tuberculosis knowledge among injection drug users in New York City.
• To identify specific areas of misunderstanding regarding TB transmission, diagnosis, and treatment adherence.
• To explore the relationship between prior TB testing history and understanding of TB concepts.

Main Methods:

• Structured interviews were conducted with 494 injection drug users in New York City.
• A subsample had their self-reported data validated through medical record reviews.
• Key knowledge areas assessed included TB transmission, distinction between reactive skin tests and active TB, and medication adherence.

Main Results:

• Most participants understood TB transmission mechanisms.
• Three-fourths of subjects did not fully grasp the difference between a reactive tuberculin skin test and active tuberculosis.
• Forty percent of subjects did not understand the importance of medication adherence for TB treatment.

Conclusions:

• Significant knowledge deficits regarding TB diagnosis and treatment exist among New York City IDUs.
• A history of reactive skin tests correlated with better understanding of the distinction between testing and active disease.
• Targeted tuberculosis education interventions are needed to address misunderstandings and improve disease control efforts in this population.